CBR International has now joined Novotech, the Asia Pacific centered biotech CRO, and will now be known as Novotech Drug Development Consulting. Our operations include full-service product development, clinical oversight, and strategic regulatory operations providing comprehensive "lab to launch" program development services. We also provide comprehensive product development services to the biotechnology, pharmaceutical, and device industries worldwide. We have a proven track record of successful FDA meetings and approvals. Our teams have the expertise to support your projects over their entire lifetimes, all the way from preclinical development through approval and post-marketing. Our expertise with the FDA process ensures we can assist clients to accelerate products to the clinic. Please contact us if you need assistance or general advice: call us at 720-746-1190 or email info@cbrintl.com.